ProCE Banner Activity

CME

Leading the Charge on Obesity Management: The Endocrinologist’s Role in Empowering Community Providers to Join the Fight

Video

Gain experts’ insights and tools for endocrinology specialists to use to support and empower community-based colleagues in successful and sustainable obesity management practices.

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits

ABIM MOC: maximum of 1.50 Medical Knowledge MOC points

Released: July 27, 2023

Expiration: July 26, 2024

No longer available for credit.

Share

Faculty

Jaime Almandoz

Jaime Almandoz, MD, MBA, MRCPI, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Daniel Bessesen

Daniel Bessesen, MD

Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
University of Colorado, School of Medicine
Denver, Colorado

Joanna Miragaya

Joanna Miragaya, MD, PhD, FACE, ABOM Diplomate

Department of Endocrinology
Wellstar Health System
Holly Springs, Georgia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Target Audience

This program is intended for endocrinologists and other HCPs who manage patients with diabetes who have experience managing obesity.

Program Learning Goal

The goal of this program is to improve the competence, skills, and performance of endocrinologists and other HCPs to support and empower community-based HCPs to optimize the management of patients with obesity.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate effective strategies to empower community-based HCPs to prioritize obesity management in their clinical practices

  • Formulate strategies to engage with community-based HCPs to disseminate the latest evidence and practical strategies for incorporating pharmacotherapy into the long-term management of obesity

  • Apply strategies to empower community-based HCPs to initiate conversations and sustainable practices that support long-term weight loss maintenance in patients with obesity

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Program Director

Daniel Bessesen, MD

Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
University of Colorado, School of Medicine
Denver, Colorado

Daniel Bessesen, MD: consultant/advisor/speaker/researcher: Novo Nordisk; independent contractor: Eli Lilly.

Primary Author

Jaime Almandoz, MD, MBA, MRCPI, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Jaime Almandoz, MD, MBA, FTOS: consultant/advisor/speaker: Lilly, Novo Nordisk.

Joanna Miragaya, MD, PhD, FACE, ABOM Diplomate

Department of Endocrinology
Wellstar Health System
Holly Springs, Georgia

Joanna Miragaya, MD, PhD, FACE, ABOM Diplomate, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from July 27, 2023, through July 26, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through CCO’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).